Try our mobile app

Published: 2022-06-24 16:34:13 ET
<<<  go to MET company page
8-K
METLIFE INC Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F false 0001099219 0001099219 2022-06-21 2022-06-21 0001099219 us-gaap:CommonStockMember 2022-06-21 2022-06-21 0001099219 us-gaap:SeriesAPreferredStockMember 2022-06-21 2022-06-21 0001099219 us-gaap:SeriesEPreferredStockMember 2022-06-21 2022-06-21 0001099219 us-gaap:SeriesFPreferredStockMember 2022-06-21 2022-06-21

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 21, 2022

 

 

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

1-15787   13-4075851
(Commission
File Number)		   (IRS Employer
Identification No.)

 

200 Park Avenue, New York, NY   10166-0188
(Address of Principal Executive Offices)   (Zip Code)

(212) 578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange
on which registered

Common Stock, par value $0.01   MET   New York Stock Exchange
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01   MET PRA   New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E   MET PRE   New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F   MET PRF   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 5.07

Submission of Matters to a Vote of Security Holders.

At MetLife, Inc.’s (the “Company’s”) annual meeting of common shareholders on June 21, 2022, the shareholders:

 

•  

elected thirteen Directors, each for a term expiring at the Company’s 2023 annual meeting of shareholders;

 

•  

ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2022; and

 

•  

approved, on an advisory basis, the compensation paid to the Company’s Named Executive Officers as disclosed in the Company’s 2022 Proxy Statement.

Election of Directors:

 

Nominee Name

    Votes For      Votes Against      Abstained      Broker Non-Votes  

Cheryl W. Grisé

      644,528,111        33,895,977        489,156        50,678,824  

Carlos M. Gutierrez

      671,202,706        7,247,734        462,804        50,678,824  

Carla A. Harris

      665,300,495        13,155,422        457,327        50,678,824  

Gerald L. Hassell

      675,636,175        2,791,448        485,621        50,678,824  

David L. Herzog

      665,385,845        13,052,671        474,728        50,678,824  

R. Glenn Hubbard, Ph.D.

      658,157,472        20,236,148        519,624        50,678,824  

Edward J. Kelly, III

      674,263,125        4,179,292        470,827        50,678,824  

William E. Kennard

      677,205,110        1,218,207        489,927        50,678,824  

Michel A. Khalaf

      677,001,172        1,453,057        459,015        50,678,824  

Catherine R. Kinney

      659,511,797        18,913,884        487,563        50,678,824  

Diana L. McKenzie

      675,949,548        2,512,738        450,958        50,678,824  

Denise M. Morrison

      668,857,352        9,600,144        455,748        50,678,824  

Mark A. Weinberger

      667,136,542        11,308,847        467,855        50,678,824  

 

     Votes For      Votes Against      Abstained      Broker Non-Votes  

Ratify the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2022

      692,195,933        36,924,292        471,843        0  

Advisory vote to approve the compensation paid to the Company’s Named Executive Officers

      646,681,597        31,245,998        985,649        50,678,824  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

METLIFE, INC.
By:  

/s/ Timothy J. Ring

Name:   Timothy J. Ring
Title:   Vice President and Secretary

Date: June 24, 2022